as per letter attached

Fund Raising View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.7%Reaction day

₹92.25

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.3%-1.4% vs market

Iron & Steel Products peers, median of 91sector-0.9%-1.8% vs sector

On the reaction day the stock moved 1.4 pts less than Nifty Microcap 250 and 1.8 pts less than its Iron & Steel Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.7-1.3-1.4-0.9-1.8

Next day

-4.6-4.0-0.6-3.4-1.3

-5.1-4.8-0.4-4.9-0.2

-4.6-3.3-1.3-4.2-0.4

-5.7-5.3-0.3-5.8+0.1

-3.0-5.2+2.2-6.4+3.5

-6.8-3.7-3.1-5.1-1.7

15d

-4.6+3.6-8.2+0.8-5.4

-7.6+0.1-7.7-3.2-4.4

-18.1-8.9-9.2-9.8-8.3

-6.2+3.2-9.4+1.3-7.5

UpDownMarket · Nifty Microcap 250Sector · Iron & Steel Products peers, median of 91Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Maiden Forgings has informed BSE that, in continuation of its December 31, 2025 intimation, it did not receive the expected funds from a proposed investor within the stipulated period due to unavoidable circumstances. As a result, the company has decided not to proceed with the allotment of shares at this stage. The matter is under consideration, and the company will take appropriate steps in line with applicable regulations. Any further developments will be communicated to the exchange in due course.

Likely market impact

This is a negative signal for shareholders as a planned fundraising has fallen through, which may delay the company's growth or expansion plans that depended on this capital infusion. It also creates near-term uncertainty about the company's funding strategy and could weigh on sentiment around the stock.